Trust Board

The Trust board comprises of six Non-Executive Directors, a Chair and six Executive Directors (senior staff of the hospital), including the Chief Executive. Collectively they take corporate responsibility for the strategic development and actions of GOSH.

The Trust Board meets six times per year and once for a strategic meeting to review past performance against the strategy and discuss future plans. 

Meet the team: 

Sir Michael Rake, Chair

Sir Michael Rake was appointed as Chair at a meeting of the Members’ Council in May 2017 and took up his post in November 2017. Sir Michael Rake’s former principal roles include Chairman of BT, Chairman (both UK and International) of KPMG, Chairman of easyJet, President of the Confederation of British Industry, Deputy Chairman of Barclays and director of the Financial Reporting Council.

New GOSH hospital CEO Mat Shaw

Mr Matthew Shaw, Chief Executive

Mr Matthew Shaw was previously the Trust's Medical Director and joined GOSH in March 2018.

Matthew is a highly experienced clinical leader. He is an orthopaedic surgeon and has been Clinical Director of the spinal unit at the Royal National Orthopaedic Hospital (RNOH) for the last seven years. He was also the Medical Director and Deputy Chief Executive of the RNOH for five years. Before joining GOSH Matthew was Medical Director for Health Provision in BUPA UK.

Matthew attends the Audit Committee; Quality, Safety and Experience Committee; Finance and Investment Committee and the People and Education Assurance Committee. 

Akhter Mateen

Akhter Mateen, Deputy Chair

Mr Akhter Mateen has an MBA in Finance and holds a non-executive director position at a not for profit international development organisation and is also a Trustee of two charities. 

Akhter was Chief Auditor at Unilever from January 2011 until December 2012 and had a 29 year career with the company during which he worked in both global and regional roles. Akhter led Unilever finance teams in Latin America, South East Asia and Australasia.

Akhter is Chair of the Audit Committee and a member of the Finance and Investment Committee.

James Hatchley, Senior Independent Director

Mr. James Hatchley has over 25 years of executive-level experience working in the financial services industry. He is currently Group Strategy Director for 3i Group plc and prior to that was European Chief Operating Officer of Kohlberg Kravis and Roberts, a US-listed global investment firm.

James Chairs the Finance and Investment Committee and is a member of the Audit Committee and the People and Education Assurance Committee. 

Lady Amanda Ellingworth, Non-Executive Director

Lady Amanda Ellingworth was a senior social worker focusing on children and families before moving into Board level roles, including 12 years on the Board of a small Foundation Trust and Chair of a large housing association. Currently, Amanda is a Director of Plan International UK and Deputy Chair of the Sir Ernest Cassel Education Trust. She was Lay Advisor of the Royal College of Emergency Medicine and Deputy Chair of Barnado’s, the major children’s charity until 2019. 

Amanda Chairs the Quality, Safety and Experience Assurance Committee. She is a member of the People and Education Assurance Committee. 

Chris Kennedy, Non-Executive Director

Chris Kennedy is a qualified accountant and is currently Chief Financial Officer of ITV plc.

Prior to this Chris was CFO of Micro Focus the British multinational software and information technology business, and ARM Holdings plc, the UK’s largest listed technology company. He has spent the last 20 years in senior global, financial and commercial roles in a variety of sectors including 5 years at EasyJet.

Chris spent 17 years at EMI as COO of EMI International running both the commercial and finance functions together with the growing digital music business, and later became CFO of the Group. Chris holds a degree in electrical sciences from Cambridge University.

Chris is a member of the Audit Committee and the Finance and Investment Committee.

Kathryn Ludlow, Non Executive Director at GOSH

Kathryn Ludlow, Non-Executive Director

Kathryn is General Counsel at Centreview Partners UK LLP and was, until April 2017, a partner at the leading international law firm, Linklaters. Over a 30 year career with Linklaters, Kathryn handled major litigation and investigations, and is a well-regarded expert in dispute resolution. Her professional expertise has crossed many sectors including accountancy, banking, mining and telecoms.

A pioneer in CSR, Kathryn was Linklaters’ first Global Pro Bono Partner and also Chaired the firm’s Corporate Responsibility Committee as well as being a trustee of legal advice charities, including the Royal Courts of Justice Citizens Advice Bureau.

Kathryn is a director of the Hall for Cornwall Trust and the International Rescue Committee UK.

Kathryn chairs the People and Education Assurance Committee and is a member of the Quality, Safety and Experience Assurance Committee. 

Professor Russell Viner, Non-Executive Director

Russell Viner joined the GOSH Board in April 2020. He is a former President of the Royal College of Paediatrics & Child Health (RCPCH) and current Professor of Adolescent Health at the UCL Institute of Child Health in London, a paediatrician who sees young people with diabetes each week at University College Hospital and he directs the Department of Health Obesity Policy Research Unit. His research focuses on population health, policy and health services for children and young people.

Russell is currently Vice-Chair of the NHS England Children and Young People’s Transformation Board, and Chair of the Stakeholder Council for the Children’s Transformation Board. He also has significant ‘hands-on’ experience within the NHS, having been Clinical Director in a busy teaching hospital and clinical director for children and young people for the NHS across London, responsible for leading healthcare strategy for London’s 2 million children and young people.

Russell is a member of the Quality, Safety and Experience Assurance Committee.

John Quinn, Chief Operating Officer at GOSH

John Quinn, Chief Operating Officer

John joined us at the end of the 2020 from Moorfields Eye Hospitals NHS Foundation Trust where he was the Chief Operating Officer.

A clinical pharmacist by background, John has also worked at UCLH and Buckinghamshire Healthcare NHS Trust. John has substantial experience of leading operationally in Trusts with strong research and commercial portfolios. John understands and is actively involved in regional conversations about improving care across North Central London.

Sanjiv Shaema, Medical Director

Dr Sanjiv Sharma, Medical Director

Sanjiv joined GOSH in 2000 as a Senior House Officer. He was appointed as a Consultant in Paediatric and Neonatal Intensive Care in 2009, and was Deputy Medical Director for Medical and Dental Education since January 2016. Sanjiv was appointed to the role of Medical Director in May 2019.

Sanjiv attends the Quality, Safety and Experience Assurance Committee. 

Darren Derby, Acting Chief Nurse

Darren Darby, Acting Chief Nurse

Darren has worked in the NHS for 30 years as a children’s nurse. He has held senior leadership and clinical roles at some of London’s largest Teaching Hospitals, including Barts Health, Kings College Hospital and Great Ormond Street.

Darren has worked as a Director of Nursing and Advanced Nurse practitioner roles specialising in Children’s Critical Care and Children’s Major Trauma. Darren is passionate about advocating for the best possible patient care, staff wellbeing and the voice of the child. He has worked and volunteered in the NHS, humanitarian and conflict zones. He was seconded from the NHS to the Ministry of Defence where he was awarded the Operational Service Medal Afghanistan.

Helen Jameson, Chief Finance Officer

Helen is responsible for the financial management of the Trust, as well as leading on estates and facilities. She is the Executive Lead for the North London Genomic Laboratory Hub which covers seven Trusts in North London including the GOSH laboratories which provide the majority of rare diseases and paediatric cancer testing for the hub. 

Helen attends the Audit Committee and the Finance and Investment Committee.

Caroline Anderson, Director of Human Resources & Organisational Development

Caroline joins the Hospital from HM Land Registry where she has been the HR&OD Director for five years. In this highly complex and political role she transformed staff engagement and empowerment through a period of organisational challenge and change.

Caroline attends the People and Education Assurance Committee and the Quality, Safety and Experience Assurance Committee. 

Zoe Asensio-Sanchez, Director of Estates and Facilities and the Built Environment

Zoe Asensio-Sanchez joined Great Ormond Street Hospital on 3 August 2020 as Director of Estates and Facilities and the Built Environment.

An architect by background, Zoe is an experienced leader in environment and infrastructure across the commercial, charity, education and health sectors.

Zoe joins the Trust's Executive Team from her previous post as Director of Estates and Facilities at Anglia Ruskin University. Prior to this she has held a number of director-level roles, including at King's College London, and Basildon and Thurrock University Hospitals NHS Foundation Trust.

Professor David Goldblatt, Director of Research and Development

Professor David Goldblatt is a Consultant Paediatric Immunologist at GOSH and Professor of Vaccinology and Immunology and Head of the Immunobiology Unit at the UCL GOS Institute of Child Health. He is a regular advisor to the World Health Organisation (WHO) on vaccines and is a Director of the WHO Reference Laboratory for Pneumococcal Serology

David is the Director of Clinical Research and Development at GOSH (2003 to present) and was the Director of the National Institute for Health Research (NIHR) Biomedical Research Centre at GOSH/UCL from 2007 to 2017. David leads the strategic development of clinical research and development across the Trust. He serves on subcommittees of the United Kingdom Department of Health Joint Committee on Vaccines and Immunisation (JCVI) has advised the US FDA and EMA on vaccine evaluation and has served as a member of MRC, Wellcome Trust and US NIH funding panels.

David attends Trust Board.

Cymbeline Moore, Director of Communications

Cymbeline is a trained journalist that has worked in communications for the NHS for the last seven years.

After working for the Trinity Mirror group of newspapers as a news editor she moved into NHS communications at Hammersmith Hospitals. During her time there she became head of public relations and then director of communications for the newly formed Imperial College Healthcare NHS Trust.

She has been head of communications for Great Ormond Street Hospital and Charity since September 2012. In this joint role she oversees all hospital and charity press and PR activity and is responsible for family stewardship, celebrity liaison and VIP visits.

Cymbeline attends Trust Board. 

From November 2019 onwards, the Trust’s register of interests, gifts, hospitality and sponsorship will be available here

Historic declarations of interests are available below:

Register of Gifts and Hospitality 2018-19

Register of Gifts and Hospitality 2017-18 

Register of Gifts and Hospitality 2016-17 

The Trust Board is the governing body of Great Ormond Street Hospital (GOSH). They are responsible for the directing and controlling the affairs of GOSH. The Board also provides a framework of governance to enable GOSH to deliver quality healthcare and health improvement.